JP2023551539A5 - - Google Patents
Info
- Publication number
- JP2023551539A5 JP2023551539A5 JP2023533236A JP2023533236A JP2023551539A5 JP 2023551539 A5 JP2023551539 A5 JP 2023551539A5 JP 2023533236 A JP2023533236 A JP 2023533236A JP 2023533236 A JP2023533236 A JP 2023533236A JP 2023551539 A5 JP2023551539 A5 JP 2023551539A5
- Authority
- JP
- Japan
- Prior art keywords
- bond
- peptide
- conjugate
- receptor
- conjugate according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119555P | 2020-11-30 | 2020-11-30 | |
| US63/119,555 | 2020-11-30 | ||
| PCT/US2021/061186 WO2022115778A1 (en) | 2020-11-30 | 2021-11-30 | Radiopharmaceutical conjugate compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551539A JP2023551539A (ja) | 2023-12-08 |
| JP2023551539A5 true JP2023551539A5 (cg-RX-API-DMAC10.html) | 2024-12-06 |
Family
ID=81753691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533236A Pending JP2023551539A (ja) | 2020-11-30 | 2021-11-30 | 放射性医薬品コンジュゲート組成物及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230158179A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4251639A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023551539A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116888138A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022115778A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023283882A1 (en) * | 2022-06-10 | 2025-01-30 | Peking University | Trifunctional compound and use thereof |
| CN120091830A (zh) * | 2022-08-24 | 2025-06-03 | 苏州创胜医药集团有限公司 | 使用抗cldn18.2抗体-放射性核素缀合物的非侵入性方法 |
| CN117645652A (zh) * | 2022-09-02 | 2024-03-05 | 核欣(苏州)医药科技有限公司 | 环肽及其制备方法、包括其的复合物、及其用途 |
| US20260083865A1 (en) * | 2022-09-07 | 2026-03-26 | 3B Pharmaceuticals Gmbh | Prostate specific membrane antigen (psma) ligands and use thereof |
| JP2025532958A (ja) * | 2022-09-29 | 2025-10-03 | ペプチドリーム株式会社 | ＥｐｈＡ２結合保留ペプチド及びそれを含む組成物 |
| WO2024073622A2 (en) * | 2022-09-29 | 2024-04-04 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting ephrin type-a receptor 2 and uses thereof |
| WO2024183634A1 (en) * | 2023-03-09 | 2024-09-12 | Norroy Bioscience Co., Ltd. | Radiolabeled antibody conjugates and uses thereof |
| JPWO2024195709A1 (cg-RX-API-DMAC10.html) * | 2023-03-17 | 2024-09-26 | ||
| CN118754936A (zh) * | 2023-03-27 | 2024-10-11 | 晶核生物医药科技(南京)有限公司 | 环状多肽类化合物及其应用 |
| EP4692105A1 (en) * | 2023-03-27 | 2026-02-11 | Bivision Pharmaceuticals, Inc | Cyclic polypeptide compound and use thereof |
| KR20260009883A (ko) * | 2023-05-24 | 2026-01-20 | 베이징 창핑 래보러토리 | 신규 삼관능 화합물 및 이의 용도 |
| EP4719498A1 (en) * | 2023-05-31 | 2026-04-08 | Full-Life Technologies UK Limited | Radioligands for targeting cell surface receptors and uses thereof |
| WO2024254339A2 (en) * | 2023-06-07 | 2024-12-12 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting glypican-3 and uses thereof |
| JP2026521249A (ja) * | 2023-06-14 | 2026-06-29 | マリアナ オンコロジー インコーポレーテッド | Ｄｌｌ３標的化ペプチド及びその構築物 |
| CR20260011A (es) * | 2023-06-14 | 2026-05-15 | Mariana Oncology Inc | Péptidos dirigidos a dll3 y sus construcciones |
| AU2024304266A1 (en) * | 2023-06-14 | 2025-12-04 | Mariana Oncology Inc. | Dll3 targeting peptides and constructs thereof |
| UY40854A (es) * | 2023-08-15 | 2025-02-28 | Novartis Ag | Péptidos cíclicos dirigidos a fap y conjugados de los mismos |
| TW202517674A (zh) | 2023-10-19 | 2025-05-01 | 德商拜耳廠股份有限公司 | 抗gpc3抗體及其放射性結合物 |
| WO2025117586A1 (en) * | 2023-11-27 | 2025-06-05 | Mariana Oncology Inc. | Dll3 targeting peptides and constructs thereof |
| WO2025137443A1 (en) | 2023-12-22 | 2025-06-26 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting somatostatin receptors and uses thereof |
| WO2025179168A1 (en) * | 2024-02-22 | 2025-08-28 | Mariana Oncology Inc. | Synthesis of dll3-binding peptides |
| CN119119174B (zh) * | 2024-09-12 | 2025-08-08 | 重庆医科大学附属第二医院 | 一种靶向caix和fap的化合物、其核素标记物、制法和应用 |
| WO2026128542A1 (en) * | 2024-12-11 | 2026-06-18 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting glypican-3 and uses thereof |
| CN119874832A (zh) * | 2025-01-13 | 2025-04-25 | 重庆医科大学 | 一种新型多肽荧光探针的制备方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017512A (en) | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
| US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| CN106573959B (zh) | 2014-06-06 | 2022-03-25 | 慕尼黑工业大学 | 修饰的环五肽及其用途 |
| US10421783B2 (en) * | 2016-02-19 | 2019-09-24 | The Curators Of The University Of Missouri | Prostate-specific membrane antigen (PSMA) targeting peptides |
| AU2017281940C1 (en) | 2016-06-24 | 2024-11-07 | University Of Iowa Research Foundation | Compositions and methods of treating melanoma |
| US11638764B2 (en) | 2018-11-08 | 2023-05-02 | Indi Molecular, Inc. | Theranostic capture agents, compositions, and methods of using and making |
| PL3997103T3 (pl) * | 2019-07-08 | 2025-03-24 | 3B Pharmaceuticals Gmbh | Związki zawierające ligand białka aktywującego fibroblasty i ich zastosowanie |
| CN118955620A (zh) * | 2019-07-08 | 2024-11-15 | 3B制药有限公司 | 包含成纤维细胞活化蛋白配体的化合物及其用途 |
-
2021
- 2021-11-30 CN CN202180092527.XA patent/CN116888138A/zh active Pending
- 2021-11-30 EP EP21899224.6A patent/EP4251639A1/en active Pending
- 2021-11-30 WO PCT/US2021/061186 patent/WO2022115778A1/en not_active Ceased
- 2021-11-30 JP JP2023533236A patent/JP2023551539A/ja active Pending
-
2022
- 2022-11-17 US US17/989,479 patent/US20230158179A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230340020A1 (en) | Peptide ligands for binding to mt1-mmp | |
| AU2024205105A1 (en) | Heterotandem bicyclic peptide complexes | |
| CN113631539B (zh) | 用于制备抗体-载荷部分偶联物的化合物及其用途 | |
| JP2024032941A (ja) | 自己安定化リンカー結合体 | |
| CA2965754C (en) | Bicyclic peptide ligands specific for mt1-mmp | |
| US8614290B2 (en) | Cancer imaging and treatment | |
| CA2824143C (en) | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof | |
| JP2015519339A5 (cg-RX-API-DMAC10.html) | ||
| ES2736106T3 (es) | Anticuerpos que se pueden conjugar mediante la transglutaminasa y conjugados producidos a partir de ellos | |
| JP2021528434A (ja) | インテグリンαｖβ３に結合するためのペプチドリガンド | |
| HUT75058A (en) | Amplification of the vitamin b12 uptake system using polymers | |
| TWI838358B (zh) | 疏水性奧瑞他汀(auristatin)f化合物及其結合物 | |
| US20090069220A1 (en) | Dna-binding polyamide drug conjugates | |
| US8008316B2 (en) | Azonafide derived tumor and cancer targeting compounds | |
| CN111971060A (zh) | 募集抗体并靶向肿瘤细胞的双功能分子 | |
| WO2023179723A1 (zh) | 亲和片段导向的可裂解片段，其设计、合成及在制备定点药物偶联物中的应用 | |
| JP7356677B2 (ja) | 複合体 | |
| CN110662759B (zh) | 肿瘤靶向肽变体 | |
| EA045834B1 (ru) | Гетеротандемные бициклические пептидные комплексы | |
| Ramos Tomillero | Linkers for bioconjugation | |
| Hudecz et al. | Peptide or protein based drug delivery and targeting systems |